Canget BioTekpharma
The major business of the Canget BioTekpharma Company is to discover, and bring to market, highly effective low toxicity anti-cancer drugs.
- Stage Product In Development
- Industry Business Products
- Location Buffalo, NY, USA
- Currency USD
- Founded April 2012
- Employees 3
- Website canget-biotek.com
Company Summary
Canget is a biotech and biopharma company spun off from Roswell Park Cancer Institute (Buffalo, NY). Canget’s technology has taken 7 years and $3M funds from federal, public and private foundations to develop its current IP portfolio. Canget was officially formed in New York State as a Limited Liability Company (LLC) on April 26, 2012 and focuses on development of novel (low toxic, highly effective and cancer-targeting) anticancer agents.
Team
-
Geoffrey WhiteDevelopment Consulting Officer
See: http://www.canget-biotek.com/leadership.html
-
Nathan R WallChief Executive Officer
See: http://www.canget-biotek.com/leadership.html
-
Fengzhi LiChief Scientific Officer
See: http://www.canget-biotek.com/leadership.html
-
Scott FriedmanLegal Counsel
See: http://www.canget-biotek.com/leadership.html
-
Brian R PettitHuman Resources Consultant
See: http://www.canget-biotek.com/leadership.html
-
Sophia L SongAccounting and Financial Officer
Ms. Sophia L Song is in charge of Canget’s accounting and financial systems. Ms. Song has a very strong education and work experience in accounting and finances. She completed her accounting major 15 years ago and worked as a certified accountant in China for several years before came to the United States. She is also interested in Finances. In this regard, she was enrolled in the State University of New York (SUNY) at Buffalo (UB) with a major i
Advisors
-
Scott FriedmanLawyerUnconfirmedSophia L SongAccountantUnconfirmed
Previous Investors
-
NIH/NCI, DOD, Public Foundations, and Private FoundationsUnconfirmedCanget FoundersUnconfirmedEquity Sharing Plan ParticipatorsUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.